170 related articles for article (PubMed ID: 21234733)
1. Phospho-STAT5 expression is associated with poor prognosis of human colonic adenocarcinoma.
Mao YL; Li ZW; Lou CJ; Pang D; Zhang YQ
Pathol Oncol Res; 2011 Jun; 17(2):333-9. PubMed ID: 21234733
[TBL] [Abstract][Full Text] [Related]
2. Expression of phosphorylated Stat5 predicts expression of cyclin D1 and correlates with poor prognosis of colonic adenocarcinoma.
Mao Y; Li Z; Lou C; Zhang Y
Int J Colorectal Dis; 2011 Jan; 26(1):29-35. PubMed ID: 21079973
[TBL] [Abstract][Full Text] [Related]
3. High-level expression of P21-Cdc/Rac-activated kinase 7 is closely related to metastatic potential and poor prognosis of colon carcinoma.
Li C; Chen J; Wang Y; Song G; Xiao C; Yan D; Zhong L; Sun X; Wang X; Yu F; Yu Y; Tang H; Peng Z
Oncotarget; 2016 Jul; 7(29):46042-46055. PubMed ID: 27323857
[TBL] [Abstract][Full Text] [Related]
4. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
Xu XY; Lin N; Li YM; Zhi C; Shen H
Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
[TBL] [Abstract][Full Text] [Related]
5. High NUSAP1 expression predicts poor prognosis in colon cancer.
Liu Z; Guan C; Lu C; Liu Y; Ni R; Xiao M; Bian Z
Pathol Res Pract; 2018 Jul; 214(7):968-973. PubMed ID: 29853313
[TBL] [Abstract][Full Text] [Related]
6. Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status.
Rego RL; Foster NR; Smyrk TC; Le M; O'Connell MJ; Sargent DJ; Windschitl H; Sinicrope FA
Br J Cancer; 2010 Jan; 102(1):165-72. PubMed ID: 19997103
[TBL] [Abstract][Full Text] [Related]
7. Expression of Tiam1 predicts lymph node metastasis and poor survival of lung adenocarcinoma patients.
Liu S; Li Y; Qi W; Zhao Y; Huang A; Sheng W; Lei B; Lin P; Zhu H; Li W; Shen H
Diagn Pathol; 2014 Mar; 9():69. PubMed ID: 24661909
[TBL] [Abstract][Full Text] [Related]
8. Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma.
Klupp F; Diers J; Kahlert C; Neumann L; Halama N; Franz C; Schmidt T; Lasitschka F; Warth A; Weitz J; Koch M; Schneider M; Ulrich A
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1548-55. PubMed ID: 25773877
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the correlation of MACC1, CD44, Twist1, and KiSS-1 in the metastasis and prognosis for colon carcinoma.
Zhu B; Wang Y; Wang X; Wu S; Zhou L; Gong X; Song W; Wang D
Diagn Pathol; 2018 Jul; 13(1):45. PubMed ID: 30021598
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
Xi HQ; Zhao P
J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of high YY1AP1 and PCNA expression in colon adenocarcinoma.
Ho YJ; Lin YM; Huang YC; Shi B; Yeh KT; Gong Z; Lu JW
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):173-180. PubMed ID: 29037809
[TBL] [Abstract][Full Text] [Related]
12. STAT3 expression in gastric cancer indicates a poor prognosis.
Kim DY; Cha ST; Ahn DH; Kang HY; Kwon CI; Ko KH; Hwang SG; Park PW; Rim KS; Hong SP
J Gastroenterol Hepatol; 2009 Apr; 24(4):646-51. PubMed ID: 19175826
[TBL] [Abstract][Full Text] [Related]
13. CIP2A is a predictor of poor prognosis in colon cancer.
Teng HW; Yang SH; Lin JK; Chen WS; Lin TC; Jiang JK; Yen CC; Li AF; Chen PC; Lan YT; Lin CC; Hsu YN; Wang HW; Chen KF
J Gastrointest Surg; 2012 May; 16(5):1037-47. PubMed ID: 22328001
[TBL] [Abstract][Full Text] [Related]
14. Decreased H2B monoubiquitination and overexpression of ubiquitin-specific protease enzyme 22 in malignant colon carcinoma.
Wang Z; Zhu L; Guo T; Wang Y; Yang J
Hum Pathol; 2015 Jul; 46(7):1006-14. PubMed ID: 25971547
[TBL] [Abstract][Full Text] [Related]
15. Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82.
Hashida H; Takabayashi A; Tokuhara T; Taki T; Kondo K; Kohno N; Yamaoka Y; Miyake M
Int J Cancer; 2002 Feb; 97(4):518-25. PubMed ID: 11802216
[TBL] [Abstract][Full Text] [Related]
16. Low level of FOXL1 indicates a worse prognosis for gastric cancer patients.
Ertao Z; Jianhui C; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C; Hui W
Tumour Biol; 2016 Aug; 37(8):11331-7. PubMed ID: 26960689
[TBL] [Abstract][Full Text] [Related]
17. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.
Guo T; Zhao S; Li Z; Li F; Li J; Gu C
Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of Src activation in stage II-III colon cancer.
Martínez-Pérez J; Lopez-Calderero I; Saez C; Benavent M; Limon ML; Gonzalez-Exposito R; Soldevilla B; Riesco-Martínez MC; Salamanca J; Carnero A; Garcia-Carbonero R
Hum Pathol; 2017 Sep; 67():119-125. PubMed ID: 28601656
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of STAT5A predicts poor prognosis in osteosarcoma.
Guo Z; Tang Y; Fu Y; Wang J
Pathol Res Pract; 2019 Mar; 215(3):519-524. PubMed ID: 30638860
[TBL] [Abstract][Full Text] [Related]
20. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
